[HTML][HTML] Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent …
S Tournayre, O Mathieu, M Villiet, N Besnard… - International Journal of …, 2023 - Elsevier
Objectives The use of extended intermittent infusion (EII) or continuous infusion (CI) of
meropenem is recommended in intensive care unit (ICU) patients, but few data comparing …
meropenem is recommended in intensive care unit (ICU) patients, but few data comparing …
[PDF][PDF] Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent …
S Tournayre, O Mathieu, M Villiet… - International Journal …, 2023 - researchgate.net
abstract Objectives: The use of extended intermittent infusion (EII) or continuous infusion (CI)
of meropenem is recommended in intensive care unit (ICU) patients, but few data comparing …
of meropenem is recommended in intensive care unit (ICU) patients, but few data comparing …
[引用][C] Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent …
S Tournayre, O Mathieu, M Villiet… - International Journal …, 2023 - hal.umontpellier.fr
Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment
in septic critically ill patients treated with extended intermittent infusion or continuous …
in septic critically ill patients treated with extended intermittent infusion or continuous …
[PDF][PDF] Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent …
S Tournayre, O Mathieu, M Villiet, N Besnard… - International Journal of …, 2023 - hal.science
abstract Objectives: The use of extended intermittent infusion (EII) or continuous infusion (CI)
of meropenem is recommended in intensive care unit (ICU) patients, but few data comparing …
of meropenem is recommended in intensive care unit (ICU) patients, but few data comparing …
[引用][C] Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent …
S Tournayre, O Mathieu, M Villiet… - International Journal …, 2023 - cnrs.hal.science
Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in
septic critically ill patients treated with extended intermittent infusion or continuous infusion …
septic critically ill patients treated with extended intermittent infusion or continuous infusion …
Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent infusion or …
S Tournayre, O Mathieu, M Villiet, N Besnard, V Brunot… - 2023 - cabidigitallibrary.org
Objectives: The use of extended intermittent infusion (EII) or continuous infusion (CI) of
meropenem is recommended in intensive care unit (ICU) patients, but few data comparing …
meropenem is recommended in intensive care unit (ICU) patients, but few data comparing …
Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent infusion or …
S Tournayre, O Mathieu, M Villiet… - International Journal …, 2023 - europepmc.org
The use of extended intermittent infusion (EII) or continuous infusion (CI) of meropenem is
recommended in ICU patients, but few data comparing these two options are available. We …
recommended in ICU patients, but few data comparing these two options are available. We …
Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent infusion or …
S Tournayre, O Mathieu, M Villiet… - International journal … - pubmed.ncbi.nlm.nih.gov
Objectives The use of extended intermittent infusion (EII) or continuous infusion (CI) of
meropenem is recommended in intensive care unit (ICU) patients, but few data comparing …
meropenem is recommended in intensive care unit (ICU) patients, but few data comparing …
[PDF][PDF] Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent …
S Tournayre, O Mathieu, M Villiet, N Besnard… - International Journal of …, 2023 - hal.science
Objectives: The use of extended intermittent infusion (EII) or continuous infusion (CI) of
meropenem is recommended in intensive care unit (ICU) patients, but few data comparing …
meropenem is recommended in intensive care unit (ICU) patients, but few data comparing …